Pharmaunternehmen entscheidet sich für die Herstellung in Australien und stimuliert die Wirtschaft zu Hause 16.03.2017 Sasmar Pharmaceuticals Sasmar, an Australian biotechnology company, announced today that is has moved all manufacturing of its family planning lines to the Australian market. Sasmar CEO John-Michael Mancini said, With many... Australia economy family planning Mehr lesen